Livzon Pharmaceutical Group Inc. financial reports, Livzon Pharmaceutical Group Inc. annual revenue in 2024. When does Livzon Pharmaceutical Group Inc. report revenue?
Livzon Pharmaceutical Group Inc. total revenue, net income and dynamics of changes in Hong Kong dollar today
The dynamics of Livzon Pharmaceutical Group Inc. net revenue grew by 754 930 491 $ compared to the previous report. Net income Livzon Pharmaceutical Group Inc. - 519 651 081 $. Information about net income is used from open sources. The dynamics of Livzon Pharmaceutical Group Inc. net income went up. The change was 226 288 174 $. The financial schedule of Livzon Pharmaceutical Group Inc. consists of three charts of the main financial indicators of the company: total assets, net revenue, net income. Livzon Pharmaceutical Group Inc. financial report on the graph shows the dynamics of assets. The value of all Livzon Pharmaceutical Group Inc. assets on the graph is shown in green.
Report date
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
and
Change (%)
Comparing current quartal report this year to quartal report last year.
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
and
Change (%)
Comparing current quartal report this year to quartal report last year.
31/03/2021
3 619 233 405.38 $
+28.47 % ↑
561 445 641.49 $
+32.3 % ↑
31/12/2020
2 803 585 272.83 $
+28.51 % ↑
316 957 534.64 $
+106.49 % ↑
30/09/2020
3 057 922 607.81 $
+20.14 % ↑
450 326 628.95 $
+38.52 % ↑
30/06/2020
2 798 862 187.77 $
+11.11 % ↑
654 074 313.03 $
+74.88 % ↑
30/09/2019
2 545 303 897.65 $
-
325 089 799.35 $
-
30/06/2019
2 519 033 557.98 $
-
374 014 936.20 $
-
31/03/2019
2 817 271 804.58 $
-
424 365 014.04 $
-
31/12/2018
2 181 621 830.28 $
-
153 496 655.57 $
-
Show:
to
Livzon Pharmaceutical Group Inc. financial report charts
The latest dates of Livzon Pharmaceutical Group Inc. financial statements available online: 31/12/2018, 31/12/2020, 31/03/2021. The dates of financial statements are strictly regulated by law and financial statements. The latest date of the financial report of Livzon Pharmaceutical Group Inc. is 31/03/2021. Gross profit Livzon Pharmaceutical Group Inc. is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services. Gross profit Livzon Pharmaceutical Group Inc. is 2 226 940 505 $
Livzon Pharmaceutical Group Inc. quarterly report dates
Cost of revenue Livzon Pharmaceutical Group Inc. is the total cost of producing and distributing of products and services of a company. Cost of revenue Livzon Pharmaceutical Group Inc. is 1 122 873 640 $ Total revenue Livzon Pharmaceutical Group Inc. refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods. Total revenue Livzon Pharmaceutical Group Inc. is 3 349 814 145 $ Operating income Livzon Pharmaceutical Group Inc. is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS). Operating income Livzon Pharmaceutical Group Inc. is 647 957 925 $
Net income Livzon Pharmaceutical Group Inc. is an entity's income minus cost of goods sold, expenses and taxes for an accounting period. Net income Livzon Pharmaceutical Group Inc. is 519 651 081 $ Current assets Livzon Pharmaceutical Group Inc. is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year. Current assets Livzon Pharmaceutical Group Inc. is 15 408 820 931 $ Total assets Livzon Pharmaceutical Group Inc. refers to the total amount of assets owned by a person or entity. Total assets Livzon Pharmaceutical Group Inc. is 21 358 886 900 $
31/03/2021
31/12/2020
30/09/2020
30/06/2020
30/09/2019
30/06/2019
31/03/2019
31/12/2018
Gross profit
Gross profit is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services.
2 406 049 147.39 $
1 657 709 933.30 $
2 032 195 027.51 $
1 862 366 999.68 $
1 637 043 594.94 $
1 617 556 576.28 $
1 831 066 923.52 $
1 256 356 711.48 $
Cost of revenue
Cost of revenue is the total cost of producing and distributing of products and services of a company.
1 213 184 257.99 $
1 145 875 339.53 $
1 025 727 580.29 $
936 495 188.09 $
908 260 302.72 $
901 476 981.69 $
986 204 881.06 $
925 265 118.79 $
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
3 619 233 405.38 $
2 803 585 272.83 $
3 057 922 607.81 $
2 798 862 187.77 $
2 545 303 897.65 $
2 519 033 557.98 $
2 817 271 804.58 $
2 181 621 830.28 $
Operating revenue
Operating revenue is revenue generated from a company's primary business activities. For example, a retailer produces revenue through merchandise sales, and a physician derives revenue from the medical services he/she provides.
-
-
-
-
2 545 303 897.65 $
2 519 033 557.98 $
2 817 271 804.58 $
2 181 621 830.28 $
Operating income
Operating income is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS).
700 071 963.97 $
255 365 013.36 $
631 043 840.20 $
781 386 319.84 $
436 925 568.99 $
357 627 979.15 $
485 774 518.37 $
62 466 503.36 $
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
561 445 641.49 $
316 957 534.64 $
450 326 628.95 $
654 074 313.03 $
325 089 799.35 $
374 014 936.20 $
424 365 014.04 $
153 496 655.57 $
R&D spending
Research and Development spending - cost of investigative activities to improve existing products and procedures or to lead to the development of new products and procedures.
250 103 304.64 $
323 963 923.02 $
300 155 352.86 $
186 427 416.49 $
209 185 288.67 $
161 911 587.28 $
149 748 353.30 $
214 587 968.41 $
Operating expense
An operating expense is an expenditure that a business incurs as a result of performing its normal business operations.
2 919 161 441.40 $
2 548 220 259.47 $
2 426 878 767.61 $
2 017 475 867.94 $
2 108 378 328.67 $
2 161 405 578.82 $
2 331 497 286.22 $
2 119 155 326.91 $
Current assets
Current assets is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year.
16 648 123 459.09 $
15 803 807 823.70 $
14 968 350 778.39 $
12 873 638 377.71 $
12 209 466 521.75 $
12 846 707 145.56 $
12 321 989 079.57 $
13 474 805 924.53 $
Total assets
Total assets refers to the total amount of assets owned by a person or entity.
23 076 742 059.13 $
22 246 896 423.63 $
20 874 098 897.47 $
18 639 355 620.99 $
17 644 783 149.33 $
18 235 092 357.86 $
17 764 767 651.56 $
18 839 799 901.49 $
Current cash
Current cash - the sum of all of the cash a company has on the date of report.
11 010 381 546.07 $
10 754 308 785.31 $
9 763 410 405.64 $
7 867 331 404.74 $
7 798 054 970.49 $
8 392 746 964.87 $
7 916 754 193.27 $
9 278 638 133.45 $
Current debt
Current debt is the portion of debt due within a year (12 months) and is listed as a current liability and part of net working capital.
-
-
-
-
4 386 949 697 $
5 380 064 476.64 $
4 375 170 343.45 $
5 801 443 064.18 $
Total cash
Total cash - the sum of all of the cash a company has on its books, including petty cash and funds on deposit in a bank.
-
-
-
-
-
-
-
-
Total debt
Total debt is a combination of both short-term and long-term debt. Short-term debts are those that must be paid back within a year. Long-term debt generally includes every liability that must be paid off in more than a year.
-
-
-
-
4 744 380 992.85 $
5 729 962 519.83 $
4 715 319 978.65 $
6 144 902 466.69 $
Debt ratio
Total debt to total assets - is a financial ratio that indicates the percentage of a company's assets that are provided via debt.
-
-
-
-
26.89 %
31.42 %
26.54 %
32.62 %
Shareholders equity
Shareholder's equity (SE) is the owner's claim after subtracting total liabilities from total assets.
13 525 349 493 $
13 081 004 626.26 $
12 533 053 076.08 $
11 989 061 937.82 $
11 733 741 625.01 $
11 380 645 419.50 $
11 917 384 182.92 $
11 508 696 010.22 $
Cash flow
Cash flow is the net amount of cash and cash-equivalents being transferred into and out of a business.
-
-
-
-
507 647 933.71 $
515 937 618.96 $
519 505 256.36 $
692 845 787.35 $
Last revenue report of Livzon Pharmaceutical Group Inc. was 31/03/2021. According to last financial report total revenue in Livzon Pharmaceutical Group Inc. was 3 619 233 405.38 Hong Kong dollar and changed by +28.47% since last year. Net income in Livzon Pharmaceutical Group Inc. was 561 445 641.49 $ in last quartal, net income changes to +32.3%.
Current cash Livzon Pharmaceutical Group Inc. - the sum of all of the cash a company has on the date of report. Current cash Livzon Pharmaceutical Group Inc. is 10 190 758 018 $
Livzon Pharmaceutical Group Inc. stocks data
1513.HK stock price
Livzon Pharmaceutical Group Inc. stock price today, 1513.HK stock quote.
